The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause

Archives of Gynecology and Obstetrics

Volumn 283, Issue 6, 2011, Pages 1319-1323

  Le Donne, Maria ^a   Caruso, Carmela ^a   Mancuso, Alfredo ^a   Costa, Gregorio ^b   Iemmo, Raffaella ^b   Pizzimenti, Giovanni ^b   Cavallari, Vittorio ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

DNA ploidy; Genistein; Hyaluronic acid; Menopause; S phase fraction; Vaginal atrophy

Indexed keywords

DNA; GENISTEIN; HYALURONIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANEUPLOIDY; ARTICLE; BIOPSY; CELL MATURATION; COLPOSCOPY; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; DNA INDEX BACKGROUND AGGREGATES AND DEBRIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PLOIDY; POSTMENOPAUSE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; S PHASE FRACTION; SQUAMOUS CELL; SUPPOSITORY; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; UTERINE CERVIX CYTOLOGY; VAGINA ATROPHY; VAGINA EPITHELIUM; VAGINA SMEAR; VAGINAL BIOPSY;

AGED; ATROPHY; BIOPSY; COLPOSCOPY; DNA; DOUBLE-BLIND METHOD; EPITHELIUM; FEMALE; FLOW CYTOMETRY; GENISTEIN; HUMANS; HYALURONIC ACID; MIDDLE AGED; PHYTOESTROGENS; PLOIDIES; POSTMENOPAUSE; SUPPOSITORIES; VAGINA; VAGINAL SMEARS; VAGINITIS;

EID: 79956065890     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1545-7     Document Type: Article

References (34)

1. Pastore LM, Carter LA, Hulka BS et al (2004) Self-reported urogenital symptoms in postmenopausal women: women's health initiative. Maturitas 49:292-303 (Pubitemid 39505183)
2. Lynch C (2009) Vaginal estrogen therapy for the treatment of atrophic vaginitis. J Women's Health (Larchmt) 18(10):1595-1606
3. Yoshimura T, Okamura H (2001) Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas 39(3):253-257 (Pubitemid 32900555)
4. Rioux JE, Devlin MC, Gelfand MM et al (2000) 17β-Estradiol vaginal tablets versus conjugated equine estrogen cream to relieve menopausal atrophic vaginitis. Menopause 7:156-161 (Pubitemid 30249896)
5. Drapier Faure E, Chantre P, Mares P (2002) Effects of a standardized soy extract on hot flushes: a multicenter, double blind, randomized, placebo controlled study. Menopause 9:329-334 (Pubitemid 36701892)
6. Villa P, Costantini B, Suriano R et al (2009) The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. J Clin Endocrinol Metab 94(2):552-558
7. Atkinson C, Compston JE, Day NE et al (2004) The effect of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79:326-333 (Pubitemid 41095988)
8. Nikander E, Rutanen EM, Nieminen P et al (2005) Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertil Steril 83:137-142 (Pubitemid 40094792)
9. Trock BJ, Hilakivi-Clarke L, Clarke R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459-471
10. Peeters PHM, Keinan-Boker L, van der Schouw YT, Grobbee DE (2003) Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 77:171-183 (Pubitemid 36197618)
11. Magee PJ, Rowland IR (2004) Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91:513-531 (Pubitemid 38584776)
12. Dixon RA (2004) Phytoestrogens. Annu Rev Plant Biol 55:225-261
13. Lavigne JA, Takahashi Y, Chandramouli GVR et al (2008) Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligomicroarray study. Breast Cancer Res Treat 110:85-98 (Pubitemid 351793861)
14. Sakamoto T, Horiguchi H, Oguma E, Kayama F (2009) Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem (in press)
15. Rice S, Whitehead SA (2006) Phytoestrogens and breast cancer - promoters or protectors? Endocr Relat Cancer 13:995-1015
16. Kim SH, Kim SH, Lee SC, Song YS (2009) Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells. Ann N Y Acad Sci 1171:196-201
17. Brown MB, Jones SA (2005) Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol 19(3):308-318 (Pubitemid 40691707)
18. Wilailak S, Rochanawutanon M, Srisupundit S et al (2004) Flowcytometric analysis of DNA ploidy and S-phase fraction of stage IIIB cervical carcinoma. Eur J Gynaecol Oncol 25(4):428-430 (Pubitemid 38954516)
19. Horn LC, Raptis G, Nenning H (2002) DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b. Anal Quant Cytol Histol 24(1):23-29 (Pubitemid 34160965)
20. Palacios S, Castel-Branco C, Cancelo MJ et al (2005) Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in post-menopausal women on hormone therapy. Maturitas 50:98-104 (Pubitemid 40094756)
21. Meisels A (1967) The maturation value. Acta Cytol 11:249-253
22. Vindelov LL, Christensen IJ, Nissen NI (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327 (Pubitemid 13087609)
23. Shankey TV, Rabinovitch PS, Bagwell B et al (1993) Guidelines for the implementation of clinical cytometry. Breast Cancer Res Treat 28:61-68
24. Malaivijitnond S, Chansri K, Kijkul P et al (2006) Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol 107(3):354-360 (Pubitemid 44363033)
25. Cline JM, Paschold JC, Anthony MS et al (1996) Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 65:1031-1035 (Pubitemid 26126840)
26. Gupta S, Kumar N, Singhal N, Manektala U, Jain S, Sodhani P (2006) Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol 34:676-681 (Pubitemid 44413692)
27. Nachtigall LE (1994) Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 61:178-180
28. van der Laak JA, de Bie LM, de Leeuw R et al (2002) The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol 55(6):446-451
29. Rader AE, Rose PG, Rodriguez M, Mansbacher S, Pitlik D, Abdul-Karim FW (1999) Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol 43(3):357-362
30. Ahn KH, Kim T, Kim YT, Lee KW, Kim SH (2009) Current hormone therapy associated with atypical squamous cells of undetermined significance in postmenopausal women. Int J Gynecol Cancer 19(4):699-702
31. Bulten J, de Wilde P, Boonstra H (2000) Proliferation in "atypical" atrophic Pap smears. Gynecol Oncol 79:225-229
32. Abati A, Jaffurs W, Wilder AM (1998) Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer (Cancer Cytopathol) 84:21825
33. Orbo A, Rydningen M, Straume B et al (2002) Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway. Int J Gynecol Cancer 12:49-56 (Pubitemid 34202949)
34. Willen R, Himmelmann A, Langstrom-Einarsson E et al (1993) Prospective malignancy grading, flow cytometric DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of uterine cervix. Anticancer Res 13:1187-1196 (Pubitemid 23247487)